Alkermes, Inc.
Waltham, MA, United States
4
Total Recalls
0
Class I Recalls
0
Ongoing Recalls
Recalls by Alkermes, Inc.
FDA Drug
Class II
Terminated
Vivitrol (naltrexone for extended-release injectable suspension) 380 mg/vial. Each Carton Contains: 1) One vial of 380 mg of Vivitrol, 2) One vial containing 4 mL of diluent, 3) One 5-mL prepackaged s
September 26, 2019
Alkermes, Inc.
16,231 kits units
FDA Drug
Class II
Terminated
Vivitrol (naltrexone for extended-release injectable suspension) 380 mg/vial. Each Carton Contains: 1) One vial of 380 mg of Vivitrol, 2) One vial containing 4 mL of diluent, 3) One 5-mL prepackaged s
August 8, 2019
Alkermes, Inc.
6,514 kits units
FDA Drug
Class II
Terminated
VIVITROL (naltrexone for extended-release injectable suspension); 380 mg vial NDC 65757-300-01; RX Only Manufactured and marketed by Alkermes, Inc., Waltham, MA 02451.
March 4, 2014
Alkermes, Inc.
4,364 vials units
FDA Drug
Class II
Terminated
VIVITROL (naltrexone for extended-release injectable suspension) a) 380 mg vial NDC 65757-303-02, b) 380 mg vial in kit NDC 65757-300-01, Rx Only Manufactured and marketed by Alkermes, Inc., Waltham,
November 6, 2012
Alkermes, Inc.
3,325 vials units